What's Actually Causing the 22-Day Average
The investigation itself rarely takes three weeks. What takes three weeks is scheduling the right people from three different systems at the right time, getting the data pulled in the right format, correlating it manually for root-cause analysis, and then drafting the CAPA form from the results. Each system dependency introduces a queue: the DCS engineer who pulls DeltaV historian data isn't the same person who runs SAP batch record queries, and neither of them are QA staff who populate Veeva. Every handoff adds days. Under FDA/EMA oversight, this isn't just an efficiency problem — it's a risk to inspection readiness and audit trail completeness.
How an AI Agent Collapses the Investigation Timeline
An AI Labor Company agent mines existing Veeva Vault QMS deviation records and QA team communication in Microsoft Teams to reconstruct the investigation workflow as it actually runs. It then deploys an agent that executes the data retrieval steps in parallel: querying DeltaV historian via OSIsoft PI for process parameter excursions in the relevant batch window, pulling SAP S/4HANA batch records for material traceability, and correlating both data sets against the deviation description before pre-populating the Veeva CAPA form — including a root-cause correlation analysis. The QA director reviews the pre-populated CAPA and approves or escalates. The agent is operational in approximately five weeks, with investigations targeted to close in under five days rather than twenty-two.
The Quality and Commercial Value of Faster Investigations
Faster CAPA closure isn't just an efficiency metric — it's a commercial one. Extended deviation investigations hold batches in quarantine, compress production scheduling flexibility, and create documentation gaps that show up in FDA/EMA inspections as procedural findings. At $150M–$800M revenue, a warning letter or import alert triggered by systemic CAPA delays has material business impact that far exceeds the cost of the investigation process itself. An agent that compresses the investigation cycle by 60–80% and maintains a clean, auditable data trail through each step is both an operational improvement and a regulatory risk management investment.
Does the agent work if our DeltaV historian is on-premises behind a firewall?
Yes — the agent architecture accommodates on-premises OSIsoft PI historian access via a secure connector. The integration approach is designed for manufacturing environments where the DCS historian is not cloud-accessible.
Who approves the CAPA before it's closed in Veeva?
Your QA director or designated quality approver reviews the pre-populated CAPA form, verifies the root-cause correlation, and approves or escalates — exactly as in your current process. The agent handles the data assembly; the approval authority remains with your qualified personnel.
Can the agent handle deviation investigations that span multiple batch records or multiple production lines?
Yes — the agent queries SAP for all relevant batch records within the scope the QA team defines and correlates across multiple production runs if the investigation requires it. Multi-batch investigations follow the same workflow, just with a broader data retrieval scope.